Diverse analytical approaches for complex oligonucleotides

Oligonucleotide therapies are novel therapeutics which have only been approved for use recently. Improvements in drug delivery, target specificity, drug stability, manufacturing capacity, analysis complexity and robust regulatory guidelines are required to unlock the true potential of oligonucleotides.

This white paper highlights how our lab uses its experience in oligo testing to work with challenging compounds and navigate regulatory requirements.